marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-02-2023
ImmunoGen ROE Ratio 2011-2024 | IMGN
Annual ROE Ratio ImmunoGen
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -143.06 | -42.79 | -49.54 | 136.8 | -1538.85 | 536.53 | 175.95 | -173.03 | -94.27 | -59.76 | -87.4 | -41.63 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 536.53 | -1538.85 | -115.09 |
Quarterly ROE Ratio ImmunoGen
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -66.9 | -116.05 | -140.01 | -114.25 | -87.8 | -92.55 | -112.63 | -140.93 | -94.47 | -71.01 | 8.93 | 80.15 | 38.78 | 92.33 | 50.97 | 9.6 | -365.04 | -774.57 | -1149.21 | -1523.84 | -1069.58 | -152.09 | 278.42 | 756.31 | 705.35 | 198.08 | 178.58 | 120.44 | 297.23 | -22.67 | -139.52 | -239.9 | -421.43 | -168.58 | -63.75 | -31.61 | -46.28 | -17.89 | -32.77 | -12.55 | -33.42 | -40.03 | -72.24 | -93.06 | -86.18 | -85.9 | -65.94 | -49.83 | -15.74 | -9.11 | -13.92 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 756.31 | -1523.84 | -98.39 |